ORIC Pharmaceuticals Inc. (ORIC) Appoints Angie You to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
ORIC Pharmaceuticals (ORIC) Appoints Angie You, Ph.D., to its Board of Directors
November 10, 2021 4:56 PM ESTORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Angie You, Ph.D., to its board of directors. Dr. You currently serves as chief executive officer of Amunix Pharmaceuticals, Inc.
We are delighted to welcome Angie to ORICs board of directors, said Jacob Chacko, M.D., president and chief executive officer. Angies broad experience spanning venture capital, a variety of business development transactions, and public company leadership will bring valuable expertise... More



